M
Mario Fernández-Ruiz
Researcher at Complutense University of Madrid
Publications - 278
Citations - 6977
Mario Fernández-Ruiz is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 36, co-authored 244 publications receiving 4954 citations. Previous affiliations of Mario Fernández-Ruiz include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
Estela Moreno-García,Pedro Puerta-Alcalde,Giuseppe Gariup,Mario Fernández-Ruiz,Luis Eduardo López Cortés,Guillermo Cuervo,Miguel Salavert,Paloma Merino,Marina Machado,Jesús Guinea,Julio García-Rodríguez,José Garnacho-Montero,Cristina Cardozo,Javier Pemán,Miguel Montejo,Jesús Fortún,Benito Almirante,C Julio Castro,Jesús Rodríguez-Baño,Javier Marugan Aguado,J A Martínez,Jorge Carratalá,Alex Soriano,Carolina Garcia-Vidal +23 more
TL;DR: This research presents a novel probabilistic approach to estimating the number of mitochondria in the response of the immune system to certain types of antibiotics.
Journal ArticleDOI
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis
Mario Fernández-Ruiz,Francisco López-Medrano,Octavio Carretero,Patricia Parra,Tamara Ruiz-Merlo,José María Aguado +5 more
TL;DR: The effect of immunomodulatory therapy with tocilizumab for coronavirus disease 2019 (COVID-19) in real-life clinical practice remains controversial as discussed by the authors .
Journal ArticleDOI
Bacteriemia por Pasteurella dagmatis en un paciente cirrótico: importancia del contacto con animales domésticos
TL;DR: La exploración física mostró una temperatura axilar de 38 ◦C sin inestabilidad hemodinámica y una placa eritematosa, empastada y con aumento de la Temperatura local en el tercio inferior de la pared del abdomen.
Journal ArticleDOI
Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods
Francisco López-Medrano,María Muñoz de la Espada,Asunción Pérez-Jacoiste Asín,Mario Fernández-Ruiz,Juan María Herrero-Martínez,J. Alonso-Carrillo,Rafael San Juan,Isabel Rodríguez-Goncer,Amado Andrés,Esther A. González,Alejandro Manrique,Iago Justo,Alberto Marcacuzco,Carmelo Loinaz,Carlos Jiménez,Carlos Lumbreras,José María Aguado +16 more
TL;DR: Invasive fungal infection, particularly intraabdominal candidiasis, exerts a negative impact on the outcome of pancreas transplant recipients (PTRs) and optimal antifungal prophylaxis in this context remains unclear.